SLC5A2 and hydrops fetalis: SGLT2 inhibitors showed an early improvement in NYHA functional class andquality of life within three to four months after starting the medication, whichwas sustained for the rest of the study, both in DAPA-HF and EMPEROR-REDUCEDtrials.